Gencurix Inc (229000) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.094x

Based on the latest financial reports, Gencurix Inc (229000) has a cash flow conversion efficiency ratio of -0.094x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.31 Billion ≈ $-891.09K USD) by net assets (₩13.99 Billion ≈ $9.48 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 229000 net asset quality score to measure how much of total assets are equity-financed.

Gencurix Inc - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Gencurix Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Gencurix Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.

Gencurix Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Gencurix Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Cytosorbents Crp NASDAQ:CTSO	-0.530x
Stria Lithium Inc V:SRA	-0.053x
Poolia AB (publ) ST:POOL-B	0.096x
OPG POWER VENTURES PLC F:OPB	N/A
Maniker KO:027740	-0.041x
FNC Entertainment Co Ltd KQ:173940	-0.285x
Caldwell Partners International Inc TO:CWL	-0.159x
Triniti Dinamik PT Tbk JK:TRUE	0.022x

Annual Cash Flow Conversion Efficiency for Gencurix Inc (2016–2025)

The table below shows the annual cash flow conversion efficiency of Gencurix Inc from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see Gencurix Inc market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩16.37 Billion ≈ $11.09 Million	₩-6.24 Billion ≈ $-4.23 Million	-0.381x	+20.79%
2024-12-31	₩14.90 Billion ≈ $10.10 Million	₩-7.17 Billion ≈ $-4.86 Million	-0.481x	+46.80%
2023-12-31	₩12.00 Billion ≈ $8.13 Million	₩-10.86 Billion ≈ $-7.36 Million	-0.905x	+43.94%
2022-12-31	₩6.48 Billion ≈ $4.39 Million	₩-10.45 Billion ≈ $-7.08 Million	-1.614x	-497.94%
2021-12-31	₩30.99 Billion ≈ $21.00 Million	₩-8.37 Billion ≈ $-5.67 Million	-0.270x	-6.05%
2020-12-31	₩53.38 Billion ≈ $36.17 Million	₩-13.59 Billion ≈ $-9.21 Million	-0.255x	+99.24%
2019-12-31	₩155.18 Million ≈ $105.16K	₩-5.22 Billion ≈ $-3.54 Million	-33.651x	-6050.17%
2018-12-31	₩9.20 Billion ≈ $6.23 Million	₩-5.03 Billion ≈ $-3.41 Million	-0.547x	+35.20%
2017-12-31	₩6.41 Billion ≈ $4.34 Million	₩-5.41 Billion ≈ $-3.67 Million	-0.844x	-15.80%
2016-12-31	₩8.20 Billion ≈ $5.56 Million	₩-5.98 Billion ≈ $-4.05 Million	-0.729x	--

About Gencurix Inc

KQ:229000 Korea Diagnostics & Research

Market Cap

$22.23 Million

₩32.80 Billion KRW

Market Cap Rank

#24677 Global

#1737 in Korea

Share Price

₩1400.00

Change (1 day)

-5.34%

52-Week Range

₩1400.00 - ₩5870.00

All Time High

₩23845.65